Physician
Obstetrics & Gynecology
Dr. Anthony J. Moorman, MD
|
|
Give Review
Anthony Moorman works in the field of Obstetrics & Gynecology. He went to medical school at Virginia Commonwealth University School of Medicine. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACOG)". Anthony J. Moorman, MD is a published doctor. He published 77 publications, including: 'Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop.' He accepts Medicare.
Publications
- Amplification of the ABL gene in T-cell acute lymphoblastic leukemia.
- Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants.
- Amplification of AML1 in acute lymphoblastic leukemia is Associated with a poor outcome.
- Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia.
- Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization.
- Impact of karyotype on treatment outcome in acute myeloid leukemia.
- Myelodysplastic syndromes associated with 11q23 abNormalities. European 11q23 Workshop participants.
- Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK.
- Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
- The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases. EU Concerted Action 11q23 Workshop participants.
- Complex hypodiploidy in acute myeloid leukaemia: a United Kingdom Cancer Cytogenetics Group study.
- No prognostic effect of additional chromosomal abNormalities in children with acute lymphoblastic leukemia and 11q23 abNormalities.
- Hematologic malignancies with t(4;11)(q21;q23)--a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants.
- Derivative chromosomes of 11q23-translocations in Hematologic malignancies. European 11q23 Workshop participants.
- Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants.
- A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin.
- Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases.
- Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia.
- The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants.
- Population-based demographic study of karyotypes in 1709 patients With adult acute myeloid leukemia.
- Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK.
- Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia.
- Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups.
- Hematological malignancies with t(9;11)(p21-22;q23)--a laboratory and clinical study of 125 cases. European 11q23 Workshop participants.
- Temporal changes in the incidence and pattern of central nervous system relapses in children With acute lymphoblastic leukaemia treated on four consecutive Medical Res...
- The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants.
- Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia.
- Secondary acute leukemia and myelodysplastic syndrome with 11q23 abNormalities. EU Concerted Action 11q23 Workshop.
- Polymorphism in glutathione S-transferase P1 is Associated with susceptibility to chemotherapy-induced leukemia.
- Karyotype and age in acute myeloid leukemia. Are they linked?
- Association of 17p loss with late-stage or refractory disease in Hematologic malignancy.
- Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia.
- Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding.
- A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and associa...
- Immunophenotype and cytogenetic characteristics in the relationship between birth weight and childhood leukemia.
- Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
- Genetic variegation of clonal architecture and propagating cells in leukaemia.
- Effect of mitoxantrone on outcome of children With first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
- Demographic, clinical, and outcome features of children With acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
- Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
- Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
- Prognostic effect of chromosomal abNormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 rando...
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abNormalities among 5876 you...
- A population-based cytogenetic study of adults With acute lymphoblastic leukemia.
- Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) With implications of cell-origin of ALL subgroups - a UK...
- Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial...
- T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECO...
- Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.
- Heterogeneous breakpoints in patients With acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21.
- Prognostic factor analysis of the survival of elderly patients With AML in the MRC AML11 and LRF AML14 trials.
- Prospective outcome data on 267 unselected adult patients With Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transpl...
- Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia.
- Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in Cancer.
- The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1.
- Acute leukemia in children With Down''s syndrome: the importance of population based study.
- Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Netwo...
- t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
- Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
- Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle.
- Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research C...
- Prognosis of children With acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
- Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?
- t(14;19)(q32;q13): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia.
- Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.
- RAS mutation in acute myeloid leukemia is Associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.
- Breakpoints of variant 9;22 translocations in Chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome.
- Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetic...
- Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Coun...
- ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
- MLL translocations With concurrent 3' deletions: interpretation of FISH results.
- Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemia.
- Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
- Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.
- Involvement of the MLL gene in T-lineage acute lymphoblastic leukemia.
- Sex ratios and the risks of haematological malignancies.
- Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abNormalities.
Schools
Virginia Commonwealth University Medical College Of Virginia School Of Medicine
Tripler Army Med Center
Procedures Preformed
- C-Section
- Colpopexy
- Colporrhaphy
- Colposcopy
- View All
Conditions Treated
- Atrophic Vaginitis
- Breech Position
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACOG)
Education
-
Tripler Army Medical Center -
Virginia Commonwealth University School of Medicine
Hospital
-
Anne Arundel Medical Center
Drug Facts
| NPI NUMBER | 1932148749 | |
| NPPES Provider LastName | MOORMAN | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 216201217 | |
| NPPES Provider State | MD | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 144.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932148749 |
| Last Name Of The Provider | MOORMAN |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
|
Dr. Maria C. Boria, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine E. Webb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leland D. Spencer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven D. Saltzman, MD
This Doctor is OpenDoctor Recommended.
|